CD Targeted Bispecific Antibody Market is expected at an 14.5% CAGR during the forecast period for 2025-2034.
InsightAce Analytic’s “Global CD Targeted Bispecific Antibody Market Research Report 2023” is a comprehensive analysis, forecast, market dynamics and major trends report covering key market data on the CD Targeted Bispecific Antibody target type segments. This market research report provides market estimation and forecast for value (US$), within CD Targeted Bispecific Antibody Market segments. The oncology market today could be quickly superseded by next-generation therapies in the upcoming forecast period. The CD Targeted Bispecific Antibody Market is driven by factors such as the rising prevalence of cancer, increasing research funding in the immune-oncology, and focus on research activities from government health institutions and pharma giants in Immuno-oncology therapy development.
The Global CD Targeted Bispecific Antibody Market is segmented on the basis of target type and region. Based on the target type, the CD Targeted Bispecific Antibody Market is divided into CD3, CD19 and CD30/CD16A. Based on region, the market is studied across North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Among that, North America held the largest share of the market, followed by Europe. On the other hand, Asia-Pacific is expected to dominate the CD Targeted Bispecific Antibody Market during the analysis of the forecast period.
| Report Attribute | Specifications |
| Growth Rate CAGR | CAGR of 14.5% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Target Type |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | Aptevo Therapeutics, Affimed GmbH, Sutro Biopharma, Inc., IGM Biosciences, Inc., Xencor, Inc., Amgen Inc., Genentech USA, Inc., Astella Pharma Inc., Ben Kang Biopharmaceutical (Shenzhen) Co., Ltd., Merus, and Regeneron Pharmaceuticals, Inc., and others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Global CD Targeted Bispecific Antibody Market by Target Type
Global CD Targeted Bispecific Antibody Market Based on Region
Europe CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country
North America CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country
Asia Pacific CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country
Latin America CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country
Middle East & Africa CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global CD Targeted Bispecific Antibody Market Snapshot
Chapter 4. Global CD Targeted Bispecific Antibody Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Target Type Estimates & Trend Analysis
5.1. By Target Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Target Type:
5.2.1. CD3
5.2.2. CD19
5.2.3. CD30/CD16A
Chapter 6. CD Targeted Bispecific Antibody Market Segmentation 2: Regional Estimates & Trend Analysis
6.1. North America
6.1.1. North America CD Targeted Bispecific Antibody Market revenue (US$ Million) estimates and forecasts By Target Type, 2021 - 2034
6.1.2. North America CD Targeted Bispecific Antibody Market revenue (US$ Million) estimates and forecasts by country, 2021 - 2034
6.2. Europe
6.2.1. Europe CD Targeted Bispecific Antibody Market revenue (US$ Million) By Target Type, 2021 - 2034
6.2.2. Europe CD Targeted Bispecific Antibody Market revenue (US$ Million) by country, 2021 - 2034
6.3. Asia Pacific
6.3.1. Asia Pacific CD Targeted Bispecific Antibody Market revenue (US$ Million) By Target Type, 2021 - 2034
6.3.2. Asia Pacific CD Targeted Bispecific Antibody Market revenue (US$ Million) by country, 2021 - 2034
6.4. Latin America
6.4.1. Latin America CD Targeted Bispecific Antibody Market revenue (US$ Million) By Target Type, (US$ Million)
6.4.2. Latin America CD Targeted Bispecific Antibody Market revenue (US$ Million) by country, (US$ Million) 2021 - 2034
6.5. Middle East & Africa
6.5.1. Middle East & Africa CD Targeted Bispecific Antibody Market revenue (US$ Million) By Target Type, (US$ Million)
6.5.2. Middle East & Africa CD Targeted Bispecific Antibody Market revenue (US$ Million) by country, (US$ Million) 2021 - 2034
Chapter 7. Competitive Landscape
7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles
7.2.1. Aptevo Therapeutics
7.2.2. Affimed GmbH
7.2.3. Sutro Biopharma, Inc.
7.2.4. IGM Biosciences, Inc.
7.2.5. Xencor, Inc.
7.2.6. Amgen Inc.
7.2.7. Genentech USA, Inc.
7.2.8. Astella Pharma Inc.
7.2.9. Ben Kang Biopharmaceutical (Shenzhen) Co., Ltd.
7.2.10. Merus
7.2.11. Regeneron Pharmaceuticals, Inc.
7.2.12. Other Key Players
Global CD Targeted Bispecific Antibody Market by Target Type
Global CD Targeted Bispecific Antibody Market Based on Region
Europe CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country
North America CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country
Asia Pacific CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country
Latin America CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country
Middle East & Africa CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country